Drug Type CAR-NK |
Synonyms- |
Target |
Mechanism CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors), CLL-1 inhibitors(C-Type lectin domain family 12 member A inhibitors), Gene transference + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Discovery | CN | 25 Nov 2022 |